ONEPOINT-PROJECTS
7.12.2017 14:02:12 CET | Business Wire | Press release
With version 17 of its leading, easy-to-use project and portfolio management (PPM) solution, onepoint PROJECTS has released the future of PPM software by making detailed planning and controlling functionality optional and therefore, enabling the rollout of professional project management for any organization. Other key features include real-time portfolio dashboards, major improvements to onepoint’s popular “Agendas” tool as well as absence management, and a new optional module integrating stakeholder management capabilities.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171207005056/en/
Keeping Projects Simple
Many projects are too simple to
manage them using traditional or agile methodologies; instead, they are
managed via to-do lists, meeting agendas and minutes and, maybe, a very
rough resources and/or cost plan spreadsheet. Creating a real project
plan, or even organizing the work in sprints feels oversized and
inefficient, so these projects are not professionally managed at all.
onepoint PROJECTS 17 solves this problem by separating detailed planning and controlling from the base product and putting it into a new optional module called “Planning & Controlling Option”. So called “simple” projects that are created without a project plan and do not feature any complex controlling functionalities, such as Earned Value or a milestone trend analysis, can be managed even by employees without project management know-how. Like in the “real world” these simple projects are managed using to-dos, meeting agendas, and minutes and optionally include very simplified resources and costs overviews. However, on the multi-project level these projects are “real” projects with goals and non-goals, take part in portfolio overviews such as the project pipeline, add to the resource utilization analysis, and even allow for optional status reporting.
“Most organizations are still using Excel sheets and whiteboards to manage most of their projects,“ said Gerald Aquila, founder & CEO of onepoint. “We believe this is because all currently available PPM solutions have been too complex – until today. If we knew 10 years ago what we know today we would have started with a clear focus on simple multi-project management and would have added optional detailed planning and controlling functionality only much later.”
Portfolio Dashboards and Agendas
onepoint PROJECTS 17 also
adds many new features for traditional, agile and hybrid project
management, such as real-time portfolio dashboards. These new overview
dashboards show the project pipeline, overall progress information, the
top projects in terms of investment size, graphical plan/actual
comparisons regarding effort, costs and budget, as well as new KPIs such
as the Scheduled Performance Indicator (SPI) and the Cost Performance
Indicator (CPI) as defined by the PMI/PMBoK standard.
In addition, the new release features major improvements to onepoint’s popular structured meeting agenda and minutes management functionality by separating agendas from the to-do list and adding a new tab “Agendas” right next to it. The new Agendas tab does not only provide an improved overview of current and past agendas, it also includes new functionality such as email invitations for participants and copying of agendas.
Stakeholder Analysis Option
With the new “Stakeholder
Analysis Option” (SAO) onepoint PROJECTS 17 closes one of the last
remaining small gaps regarding completeness according to the IPMA
standard. As we understand that stakeholder management is very important
for many customers, though not applicable for others, we decided to
package this new feature in the form of an optional module.
The new option features a revision-safe stakeholder engagement plan complete with measures and an integrated stakeholder analysis controlling tool in the form of a bubble chart with the common dimensions power, interest and attitude. Optionally, you can also include a new “Stakeholders” traffic light into your status reporting.
Further improvements include improved absence management features, such as bulk-importing absences via Excel sheets and ultralight absence request workflows. The new release also includes close to 100 smaller improvements based on end-user feedback from existing customers.
onepoint PROJECTS 17 Group Server is available at no charge for up to 4 users. A free 30 day test drive of onepoint PROJECTS 17 Enterprise Server or Cloud with the complete functionality including optional modules can be requested via www.onepoint-projects.com . For more information about the new release or for inquiries about enterprise licensing and pricing, please contact our sales team via info@onepoint-projects.com or +43 316 267 267 0.
About onepoint PROJECTS
onepoint PROJECTS is the leading provider of easy-to-use, hybrid project and portfolio management solutions for innovative small and medium-sized project organizations. Unlike traditional PPM software, onepoint PROJECTS integrates simple, traditional, agile and Jira projects into a single project portfolio and resource utilization database. onepoint enables project-oriented organizations to increase project and portfolio transparency, shorten project lead times, automate best practices and optimize resource utilization. By building on open standards and technologies, providing both cloud-based/SaaS and on-premise installations and with its strategic focus on making PM systems easy to deploy, onepoint redefines ROI for project management solutions.
The company and product names mentioned are trademarks of their respective owners as long as they are registered.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171207005056/en/
Contact:
onepoint PROJECTS GmbH
Gerald Aquila
www.onepoint-projects.com
Phone:
+43 316 267 267 0
Fax: +43 316 267 267 99
Email:info@onepoint-projects.com
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher24.4.2026 16:37:00 CEST | Press release
Compass is the most advanced company in classic psychedelics and has generated positive data from two ongoing large, well controlled Phase 3 clinical trials, designed to uphold the highest regulatory standardsFDA grants Compass NDA rolling submission and review request, based on Phase 3 dataCNPV awarded for COMP360, Compass’ proprietary formulation of synthetic psilocybin, for treatment-resistant depression (TRD)CNPV further accelerates momentum and Compass is confident and ready to deliver for patients Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the U.S. Food and Drug Administration (FDA) granted Compass NDA rolling review request and selected COMP360, Compass’ proprietary formulation of synthetic psilocybin, for the Commissioner's National Priority Voucher (CNPV) program for treatment-resistant depression (TRD). Companies selected for the voucher program will be en
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
